Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Kidney Transplant

For kids with kidney disease, pediatric expertise is key — but not always close by

Jaxon Green, 6, was diagnosed with kidney disease the day he was born. His illness meant that for years his life would depend on daily dialysis. And because his family lives in Tamaqua, a rural Pennsylvania town, his diagnosis also meant taking frequent two-hour trips to Philadelphia to see the…

Tribune News Service

Reality of overseas organ transplants / Lack of organ donors needs to be immediately addressed

A Tokyo-based nonprofit organization called the Intractable Disease Patient Support Association is suspected of having facilitated a kidney transplant that used a trafficked organ from a living donor overseas. The Yomiuri Shimbun asked experts in the relevant legal and medical systems for their opinion on this matter. In this installment,…

The Japan News/Yomiuri

The struggle for kid-ney care

Pediatric nephrology is a niche field — and specialists are not spread out evenly across the country

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

NPO planned organ transplants in Sri Lanka

In a case of suspected organ trafficking in living donor kidney transplants, a nonprofit organization in Japan had planned transplants in Sri Lanka this year and told an overseas coordinator it would send "two patients [at intervals] for a total of about 10 patients," The Yomiuri Shimbun has learned from…

The Japan News/Yomiuri

Fake passport used to pass off transplant as between relatives

The price per kidney was 15,000, dollars the equivalent today of about 2 million yen. The kidney transplant for the Japanese patient was conducted in the Central Asian country of Kyrgyzstan. A Japanese nonprofit organization acted as an intermediary. A passport was forged for the Ukrainian donor to make it…

The Japan News/Yomiuri

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has cleared the Eledon Pharmaceuticals’ (NASDAQ:ELDN) Investigational New Drug (IND) application to evaluate Tegoprubart for the prevention of organ rejection in patients receiving a kidney transplant. Eledon shares traded in a range of $2.89 to $3.16 on a day volume of 31.27 thousand…

Benzinga

A Seriously Ill Mom Is In Desperate Need Of A Kidney Transplant

A family have released before and after pictures of a seriously ill mom in desperate need of a kidney transplant.

Zenger

Read news from The Economist, FT, and more,
with one subscription

What is lupus? New treatment could end the need for lifelong medication

Three patients have undergone CAR T-cell therapy, which genetically alters their immune system to protect their organs

Evening Standard

Dual therapy helps transplant patients

An Australian study has revealed how a combination of existing therapies can help kidney transplant patients who go on to develop cancer.

Crikey

AlloVir's Posoleucel Shows Early Safety In Kidney Transplant Recipients

AlloVir Inc (NASDAQ:ALVR) announced preliminary, blinded data from an ongoing Phase 2 study of posoleucel for BK viremia (BKV) in adult kidney transplant recipients. These data provide an early indication of the safety and tolerability profile of posoleucel in kidney transplant recipients with BK viremia, which is associated with reduced graft survival and…

Benzinga

Sci-Five | The Hindu Science Quiz: On transplants

Test your Science quotient with this quiz

The Hindu

1 2 3 4

People

Selena Gomez

1,163 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

329 stories

Yomiuri Shimbun

321 stories

US Food and Drug Administration

63 stories

Royal Adelaide Hospital

24 stories

NPO

23 stories

Aneurin Bevan University Health Board

Aerie Pharmaceuticals

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.